The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II - Therapy
about
The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1- blood pressure measurement, diagnosis and assessment of riskEstimate of the benefits of a population-based reduction in dietary sodium additives on hypertension and its related health care costs in CanadaGuidelines for the management of chronic kidney diseaseOptimal waist circumference cutoff values for the diagnosis of abdominal obesity in korean adultsThe 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapyHow evidence-based are the recommendations in evidence-based guidelines?Sunitinib therapy for metastatic renal cell carcinoma: recommendations for management of side effects.Adherence level of antihypertensive agents in coronary artery disease.Hypertension and type 2 diabetes: what family physicians can do to improve control of blood pressure--an observational study.The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2--therapy.Efficacy of a family practice-based lifestyle intervention program to increase physical activity and reduce clinical and physiological markers of vascular health in patients with high normal blood pressure and/or high normal blood glucose (SNAC): stUnderrepresentation of individuals 80 years of age and older in chronic disease clinical practice guidelinesImpact of ethnic-specific guidelines for anti-hypertensive prescribing in primary care in England: a longitudinal study.An integrated approach to preventing cardiovascular disease: community-based approaches, health system initiatives, and public health policyDo beta-blockers have a role in treating hypertension? Yes.Pathophysiology and Medical Treatment of Carotid Artery Stenosis.Improving clinician self-efficacy does not increase asthma guideline use by primary care clinicians.Comprehensive cardiovascular risk management--what does it mean in practice?Cholesterol lowering for secondary prevention: what statin dose should we use?Diuretics: a modern day treatment option?Intensive management of risk factors for accelerated atherosclerosis: the role of multiple interventions.Preeclampsia and future cardiovascular risk.The 2007 Canadian Hypertension Education Program recommendations: the scientific summary - an annual update.More medications, fewer pills: combination medications for the treatment of hypertension.The vasodilatory beta-blockers.Adding "value" to clinical practice guidelines.Evolving treatment options for prevention of cardiovascular events in high-risk hypertensive patients.Cardiovascular risk reduction via telehealth: a feasibility study.Enhancing hypertension awareness and management in the elderly: lessons learned from the Airdrie Community Hypertension Awareness and Management Program (A-CHAMP)AGREEing on Canadian cardiovascular clinical practice guidelinesThe 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.Antihypertensive medication use by recently diagnosed hypertensive CanadiansPolypill: for Pollyanna.Drug management for hypertension in type 2 diabetes in family practice.Management of atherothrombotic risk factors in high-risk Canadian outpatients.Salt and high blood pressure.7th Brazilian Guideline of Arterial Hypertension: Chapter 8 - Hypertension and Associated Clinical ConditionsPrevention of NSAID-related upper gastrointestinal toxicity: a meta-analysis of traditional NSAIDs with gastroprotection and COX-2 inhibitors.Tight blood pressure control in diabetes: evidence-based review of treatment targets in patients with diabetes.The Collaborative Cardiovascular Risk Reduction in Primary Care (CCARP) study.
P2860
Q24645401-7806EB18-3888-40F2-9EC8-8407D835F93EQ24645546-F12CBFDB-4E33-424F-9395-CB73E9DD76C2Q24657844-38E434BD-8787-4611-8DCD-AE9E706B217BQ26823152-D66E99F7-AF59-42F4-BAB3-173B6E27971DQ28211654-9121C999-F69C-4F80-B817-750E03369848Q28469272-BABFAAE4-0CF8-4635-BC12-1A8366532BC3Q33379941-6A4334FA-AC8D-4D64-8382-F43BCFADE2FAQ33696605-4F34B2C3-0F94-4625-93F6-FD62C520D2B1Q33990899-2EC1B630-AF62-4CFA-811E-C13F3D4D292BQ34607311-EAA4F75F-9A8C-4C30-86F1-58BFB71F8910Q34623616-F49ABA7D-02EC-473C-A2C3-ECC3398EA596Q35102589-5EB0C451-FEAB-4BAC-827B-EA91AC09CEA7Q35102836-2F5B541C-0658-429C-ABE7-B3C918DD9E82Q35727709-A3556FA2-51C8-4FE6-930C-73D7E3748B4FQ35951348-B07757C0-4851-444D-AC35-DA47946467A1Q36065338-AB90E5ED-4AF3-4FF0-823B-121F6C6CF57DQ36098957-D56CD73B-DFF8-4089-AA63-191455F0A104Q36536165-C76B78F3-DA1E-46F2-9897-8DE367210FCBQ36536175-78832415-CDCE-4025-9267-79E897ADB442Q36609875-005A0E7C-B36B-4127-A4D9-D0229C7975D6Q36705451-8D5B9527-F96B-437D-9357-B2F06CDFC458Q36752103-82241BE5-F351-4711-BAF3-3F6E4A6C6EF5Q36834042-C8F9A98F-1BF6-40B9-8255-DE5FBA6AEC70Q36834052-62577CE0-55E0-43B5-BCDE-9D409167D395Q36905034-EE9B7348-6817-4478-9A49-BEBBA0C04735Q36943116-B26BBBFE-6010-411E-8FBB-D950EE674F97Q36989404-55BEF0CF-EB7C-4F40-986C-C43DCD869FE2Q37073597-550FDE0F-0797-4907-BA3A-54A0B7A0E601Q37092825-151BD58D-17F0-48AA-BD26-06126D7942B3Q37098293-576CD68B-9694-41EF-AFDE-E13EE3DF2D54Q37098401-DF22A93D-130D-4DB1-81DC-1C6D3EF284D7Q37116268-8EFDDAE9-813B-439A-A7D9-4E876834ADE1Q37244546-3B319D40-8132-4120-9006-32A962B81249Q37283216-A431E51E-042C-4F4F-A76C-3A118E347409Q37293740-0F9D1B7F-E346-40F2-965B-C3AA0776AA70Q37498900-FBF479AF-C7B9-4877-B64A-1AAB206E15E7Q37656189-9D64CC21-AE13-4DA4-87EC-32B597EC562CQ37893966-E0B726F6-099A-412D-A8AB-DD4EBBCF4907Q37964515-7B0A0C8F-57D9-47A8-BFEA-D135F9B858AEQ42961051-B4C9EED0-F6EF-47C4-9143-0CD07BCE44AF
P2860
The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II - Therapy
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The 2006 Canadian Hypertension ...... ypertension: Part II - Therapy
@ast
The 2006 Canadian Hypertension ...... ypertension: Part II - Therapy
@en
The 2006 Canadian Hypertension ...... ypertension: Part II - Therapy
@nl
type
label
The 2006 Canadian Hypertension ...... ypertension: Part II - Therapy
@ast
The 2006 Canadian Hypertension ...... ypertension: Part II - Therapy
@en
The 2006 Canadian Hypertension ...... ypertension: Part II - Therapy
@nl
prefLabel
The 2006 Canadian Hypertension ...... ypertension: Part II - Therapy
@ast
The 2006 Canadian Hypertension ...... ypertension: Part II - Therapy
@en
The 2006 Canadian Hypertension ...... ypertension: Part II - Therapy
@nl
P2093
P2860
P1476
The 2006 Canadian Hypertension ...... ypertension: Part II - Therapy
@en
P2093
Alain Milot
Alexander G Logan
B Hemmelgarn
Bruce Culleton
Carol Herbert
Charlotte Jones
Ellen Burgess
Ernesto L Schiffrin
Finlay A McAlister
George Carruthers
P2860
P304
P356
10.1016/S0828-282X(06)70280-X
P407
P50
P577
2006-05-15T00:00:00Z